- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

EU-India Trade Talks Jeopardizing Access to Cheap Medicines Around World

© Sputnik / Sergey Pyatakov / Go to the mediabankPills packed at a blister machine. File photo
Pills packed at a blister machine. File photo - Sputnik International
Subscribe
MSF agency called on Indian Prime Minister to reject EU demands to limit the production and export of generic medicines from India.

MOSCOW (Sputnik) — The Doctors Without Borders (MSF) aid agency called on Tuesday on Indian Prime Minister Narendra Modi to resist EU demands to limit the production and export of generic medicines from India.

AIDS Ribbon - Sputnik International
UNAIDS Head Hopes to End Worldwide AIDS Epidemic by 2030
On Wednesday, Modi and European officials are expected to announce, at a EU-India summit in Brussels, the resumption of bilateral talks on a free trade agreement that stalled after the bloc banned the sale of some 700 India-made generic drugs in July 2015.

"With the EU-India trade negotiations set to resume, there’s still so much at stake for access to medicines. This EU-India Summit is where Prime Minister Modi needs to stand firm against Europe and tell them ‘no, India is not going to shut down the pharmacy of the developing world – too many lives are on the line," South Asia regional head of MSF’s Access Campaign Leena Menghaney was quoted in the agency's statement as saying.

Medecins Sans Frontieres (MSF) - Sputnik International
MSF Reports Airstrikes Destroy Hospital in Syria's Idlib
According to MSF, the agency purchases 97 percent of the antiretroviral medicines it uses to treat 230,000 people for HIV, and three-quarters of the anti-tuberculosis medicines it administers to over 23,000 people from Indian generic-producing companies.

"India is such a vital source of affordable, generic life-saving medicines on which millions of people around the world rely, that any blow to the pharmacy of the developing world would have disastrous consequences… The reality is we wouldn’t be able to treat as many people if it weren’t for affordable generic medicines from India," MSF International President Joanne Liu added.

The agency warned that any delay or interruption in the treatment for many diseases caused by the efforts of the European Union to enforce intellectual property rights in India could have serious health consequences.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала